APA (7th ed.) Citation

C, S. Y., C, S., E, B., G, M., FS, C., & M, D. (2024). Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 30(6), 513. https://doi.org/10.1016/j.eprac.2024.03.388

Chicago Style (17th ed.) Citation

C, Seng Yue, Scarsi C, Bettazzi E, Mautone G, Celi FS, and Ducharme M. "Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 30, no. 6 (2024): 513. https://doi.org/10.1016/j.eprac.2024.03.388.

MLA (9th ed.) Citation

C, Seng Yue, et al. "Proton Pump Inhibitors Do Not Affect the Bioavailability of a Novel Liquid Formulation of Levothyroxine." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 30, no. 6, 2024, p. 513, https://doi.org/10.1016/j.eprac.2024.03.388.